M Franklin Berger

Affiliations

  • at Atea Pharmaceuticals Inc. (AVIR), 2025-06-24
  • at Kezar Life Sciences Inc. (KZR), 2025-06-23
  • at Essa Pharma Inc. (EPIX), 2024-03-28
  • Director at Rain Oncology Inc. (RAIN), 2024-01-26
  • Director at Atreca Inc. (BCEL), 2023-06-15
  • Director at Five Prime Therapeutics Inc. (FPRX), 2021-04-19
  • Director at Proteostasis Therapeutics Inc. (PTI), 2020-07-01
  • Director at Tocagen Inc (TOCA), 2019-10-05
  • Director at Immune Design Corp. (IMDZ), 2019-04-04
  • Director at Seattle Genetics Inc (SGEN), 2014-02-25
  • Director at Asterias Biotherapeutics Inc. (NONE), 2013-09-28
  • Director at Biotime Inc (BTX), 2013-08-22
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AVIR $3.36 10,000 $33,614.00 476,897 2025-01-16 Filing
AVIR $3.19 15,000 $47,884.50 466,897 2025-01-15 Filing
AVIR $3.36 10,000 $33,614.00 476,897 2025-01-16 Filing
AVIR $3.19 15,000 $47,884.50 466,897 2025-01-15 Filing
EPIX $5.73 23,259 $133,274.07 784,404 2023-11-21 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AVIR $2.85 359,606 $1,023,474.64 451,897 2024-12-10 Filing
EPIX $2.42 34,334 $83,088.28 684,404 2022-12-21 Filing
EPIX $2.41 37,889 $91,312.49 718,738 2022-12-21 Filing
EPIX $2.53 43,617 $110,351.01 756,627 2022-12-20 Filing
EPIX $2.67 50,000 $133,500.00 800,244 2022-12-16 Filing